Recent Updates
-
Population Health Management Market Size, Share & Industry Analysis, By Component (Software, and Services), By Platform (Cloud-based, and On-premise), By End User (Healthcare Providers, Healthcare Payers, and Others), and Regional Forecast
https://www.fortunebusinessinsights.com/industry-reports/population-health-management-market-100626
Population Health Management Market Size, Share & Industry Analysis, By Component (Software, and Services), By Platform (Cloud-based, and On-premise), By End User (Healthcare Providers, Healthcare Payers, and Others), and Regional Forecast https://www.fortunebusinessinsights.com/industry-reports/population-health-management-market-100626WWW.FORTUNEBUSINESSINSIGHTS.COMPopulation Health Management Market Size & Share Report, 2030The global population health management market size stood at USD 21.40 billion in 2018 and is projected to reach USD 91.43 billion by 2026, exhibiting a CAGR of 19.9% during the forecast period.0 Comments 0 Shares 733 ViewsPlease log in to like, share and comment! -
Monoclonal Antibody Therapy Market Size, Share & COVID-19 Impact Analysis, By Type (Human mAb, Humanized mAb, Chimeric mAb, and Murine mAb), By Application (Cancer, Autoimmune Diseases, and Others)
https://www.fortunebusinessinsights.com/monoclonal-antibody-therapy-market-102734
Monoclonal Antibody Therapy Market Size, Share & COVID-19 Impact Analysis, By Type (Human mAb, Humanized mAb, Chimeric mAb, and Murine mAb), By Application (Cancer, Autoimmune Diseases, and Others) https://www.fortunebusinessinsights.com/monoclonal-antibody-therapy-market-102734Monoclonal Antibody Therapy Market Size, Growth, Trends, 2028The global monoclonal antibody therapy market size is projected to grow from $178.50 billion in 2021 to $451.89 billion in 2028 at a CAGR of 14.1%0 Comments 0 Shares 668 Views -
Bone Growth Stimulator Market Size, Share & COVID-19 Impact Analysis, By Product (Bone Growth Stimulation Devices, Bone Morphogenetic Proteins (BMP), Platelet-Derived Growth Factor (PDGF)); By Application (Spinal Fusion, Maxillofacial & Dental, Nonunion and Union Bone Fractures, and Others) and By End-user (Hospitals & ASCs, Speciality Clinics, Home Care and Others) and Regional Forecasts
https://www.fortunebusinessinsights.com/industry-reports/bone-growth-stimulators-market-100161
Bone Growth Stimulator Market Size, Share & COVID-19 Impact Analysis, By Product (Bone Growth Stimulation Devices, Bone Morphogenetic Proteins (BMP), Platelet-Derived Growth Factor (PDGF)); By Application (Spinal Fusion, Maxillofacial & Dental, Nonunion and Union Bone Fractures, and Others) and By End-user (Hospitals & ASCs, Speciality Clinics, Home Care and Others) and Regional Forecasts https://www.fortunebusinessinsights.com/industry-reports/bone-growth-stimulators-market-100161WWW.FORTUNEBUSINESSINSIGHTS.COMBone Growth Stimulator Market Size, Share | Growth, 2021-2028The global bone growth stimulator market is anticipated to grow from $1.83 billion in 2021 to $2.55 billion in 2028 at a CAGR of 4.8% in forecast period0 Comments 0 Shares 782 Views -
Ophthalmic Devices Market Size, Share & COVID-19 Impact Analysis, By Surgical (Implants, Consumables, and Equipment) and Vision Care (Contact Lenses and Ocular Health) By End User (Hospitals, Ophthalmic Clinics and Others) Regional Forecast
https://www.fortunebusinessinsights.com/ophthalmic-devices-market-102187
Ophthalmic Devices Market Size, Share & COVID-19 Impact Analysis, By Surgical (Implants, Consumables, and Equipment) and Vision Care (Contact Lenses and Ocular Health) By End User (Hospitals, Ophthalmic Clinics and Others) Regional Forecast https://www.fortunebusinessinsights.com/ophthalmic-devices-market-102187Ophthalmic Devices Market Size & Share | Global Industry Report [2030]The global ophthalmic devices market size was $25.04 billion in 2019 & is projected to reach $32.36 billion by 2027, exhibiting a CAGR of 4.2% in forecast period0 Comments 0 Shares 775 Views -
Cystic Fibrosis Market Size, Share & Covid-19 Impact Analysis, By Drug Class (Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), Bronchodilators, Mucolytic, Pancreatic Enzyme Supplement, and Others)
https://www.fortunebusinessinsights.com/cystic-fibrosis-market-102958
Cystic Fibrosis Market Size, Share & Covid-19 Impact Analysis, By Drug Class (Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), Bronchodilators, Mucolytic, Pancreatic Enzyme Supplement, and Others) https://www.fortunebusinessinsights.com/cystic-fibrosis-market-102958Cystic Fibrosis Market Size, Growth, Share | Global Report, 2027The global cystic fibrosis market size stood at USD 5.12 billion in 2019 and is projected to reach USD 31.88 billion by 2027, exhibiting a CAGR of 24.4% during the forecast period.0 Comments 0 Shares 715 Views -
A spirometer is a medical device used to measure the volume of air that an individual inhales or exhales as a function of time. This device is commonly used to assess lung function and diagnose respiratory conditions. Spirometry is the most common pulmonary function test, and it plays a crucial role in the evaluation of various respiratory disorders.
https://www.fortunebusinessinsights.com/industry-reports/spirometers-market-100486A spirometer is a medical device used to measure the volume of air that an individual inhales or exhales as a function of time. This device is commonly used to assess lung function and diagnose respiratory conditions. Spirometry is the most common pulmonary function test, and it plays a crucial role in the evaluation of various respiratory disorders. https://www.fortunebusinessinsights.com/industry-reports/spirometers-market-100486WWW.FORTUNEBUSINESSINSIGHTS.COMSpirometer Market Trends | Key Industry Developments [2030]The global spirometer market size is projected to grow from $613.3 million in 2023 to $891.5 million by 2030, at a CAGR of 5.5% during the forecast period0 Comments 0 Shares 745 Views -
The U.S. Substance Use Disorder (SUD) Treatment Market is an important aspect of the healthcare industry in the United States. Substance Use Disorder refers to the misuse or overuse of substances such as alcohol, illicit drugs, and prescription medications, leading to negative consequences for physical and mental health.
https://www.fortunebusinessinsights.com/u-s-substance-use-disorder-treatment-market-107172
Here are some key points about the U.S. Substance Use Disorder Treatment Market:
1. Market Size and Growth: The market for Substance Use Disorder treatment in the U.S. is substantial, driven by the prevalence of substance abuse issues. It includes a wide range of services, from outpatient counseling to inpatient rehabilitation programs.
2. Treatment Modalities:
• Outpatient Services: These include individual and group counseling, behavioral therapy, and medication-assisted treatment (MAT) provided in an outpatient setting.
• Inpatient Services: This involves residential treatment, where individuals live at a facility for a period of time and receive intensive therapy and support.
• Detoxification Services: Medical supervision during the withdrawal process to manage potentially dangerous symptoms.
• Medication-Assisted Treatment (MAT): The use of medications (e.g., methadone, buprenorphine) in combination with counseling and behavioral therapies for the treatment of substance use disorders, particularly opioid use disorder.
3. Regulatory Environment: The Substance Abuse and Mental Health Services Administration (SAMHSA), a branch of the U.S. Department of Health and Human Services, plays a significant role in overseeing and regulating Substance Use Disorder treatment programs.
4. Private and Public Providers: Substance use disorder treatment services are provided by a combination of private and public entities. Private providers include for-profit and non-profit organizations, while public providers may be funded by state or federal agencies.
5. Insurance Coverage: Access to SUD treatment services can be influenced by insurance coverage. The Affordable Care Act (ACA) and Mental Health Parity and Addiction Equity Act (MHPAEA) have expanded insurance coverage for mental health and substance use disorder services.
6. Challenges:
• Stigma: There is still a significant stigma associated with substance use disorders, which can hinder individuals from seeking treatment.
• Access to Care: Disparities in access to quality treatment services exist, particularly in rural or underserved areas.
• Coordination of Care: Coordinating care across different providers and settings can be challenging, especially for individuals with co-occurring mental health conditions.
The U.S. Substance Use Disorder (SUD) Treatment Market is an important aspect of the healthcare industry in the United States. Substance Use Disorder refers to the misuse or overuse of substances such as alcohol, illicit drugs, and prescription medications, leading to negative consequences for physical and mental health. https://www.fortunebusinessinsights.com/u-s-substance-use-disorder-treatment-market-107172 Here are some key points about the U.S. Substance Use Disorder Treatment Market: 1. Market Size and Growth: The market for Substance Use Disorder treatment in the U.S. is substantial, driven by the prevalence of substance abuse issues. It includes a wide range of services, from outpatient counseling to inpatient rehabilitation programs. 2. Treatment Modalities: • Outpatient Services: These include individual and group counseling, behavioral therapy, and medication-assisted treatment (MAT) provided in an outpatient setting. • Inpatient Services: This involves residential treatment, where individuals live at a facility for a period of time and receive intensive therapy and support. • Detoxification Services: Medical supervision during the withdrawal process to manage potentially dangerous symptoms. • Medication-Assisted Treatment (MAT): The use of medications (e.g., methadone, buprenorphine) in combination with counseling and behavioral therapies for the treatment of substance use disorders, particularly opioid use disorder. 3. Regulatory Environment: The Substance Abuse and Mental Health Services Administration (SAMHSA), a branch of the U.S. Department of Health and Human Services, plays a significant role in overseeing and regulating Substance Use Disorder treatment programs. 4. Private and Public Providers: Substance use disorder treatment services are provided by a combination of private and public entities. Private providers include for-profit and non-profit organizations, while public providers may be funded by state or federal agencies. 5. Insurance Coverage: Access to SUD treatment services can be influenced by insurance coverage. The Affordable Care Act (ACA) and Mental Health Parity and Addiction Equity Act (MHPAEA) have expanded insurance coverage for mental health and substance use disorder services. 6. Challenges: • Stigma: There is still a significant stigma associated with substance use disorders, which can hinder individuals from seeking treatment. • Access to Care: Disparities in access to quality treatment services exist, particularly in rural or underserved areas. • Coordination of Care: Coordinating care across different providers and settings can be challenging, especially for individuals with co-occurring mental health conditions.U.S. Substance Use Disorder Treatment Market Size Report, 2029The U.S. substance use disorder treatment market size is projected to grow from $37.24 billion in 2022 to $60.18 billion by 2029, at a CAGR of 7.1%0 Comments 0 Shares 829 Views -
The spirometer market refers to the global market for spirometry devices and related accessories. Spirometry is a medical test used to measure lung function by assessing the volume and flow of air that is inhaled and exhaled by the lungs. It is an essential tool in the diagnosis and monitoring of various respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and interstitial lung disease.
https://www.fortunebusinessinsights.com/industry-reports/spirometers-market-100486
The market for spirometers includes a wide range of products, from basic handheld devices for simple lung function testing to more advanced systems used in clinical settings and hospitals. These devices can be standalone spirometers or integrated into larger diagnostic systems.
Factors driving the spirometer market include:
1. Increasing Prevalence of Respiratory Diseases: The rising incidence of respiratory diseases globally, including COPD, asthma, and other conditions, is a major driver for the spirometer market.
2. Aging Population: As the global population continues to age, the demand for respiratory care and diagnostic tools like spirometers is expected to increase.
3. Technological Advancements: Ongoing advancements in technology have led to the development of more accurate and user-friendly spirometry devices, which can further drive market growth.
4. Growing Awareness and Emphasis on Preventive Healthcare: Awareness about the importance of early detection and management of respiratory conditions is leading to increased adoption of spirometry as a diagnostic tool.
5. Regulatory Support: Government regulations and policies mandating the use of spirometry in certain clinical settings can drive market growth.
6. Telemedicine and Remote Monitoring: The COVID-19 pandemic has accelerated the adoption of telemedicine, which may boost the demand for portable and easy-to-use spirometry devices for remote monitoring of respiratory conditions.
7. Increasing Healthcare Expenditure: The overall increase in healthcare spending, especially in emerging markets, can contribute to the growth of the spirometer market.
8. Research and Development: Ongoing research and development in the field of respiratory medicine may lead to the introduction of innovative spirometry technologies.
The spirometer market refers to the global market for spirometry devices and related accessories. Spirometry is a medical test used to measure lung function by assessing the volume and flow of air that is inhaled and exhaled by the lungs. It is an essential tool in the diagnosis and monitoring of various respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and interstitial lung disease. https://www.fortunebusinessinsights.com/industry-reports/spirometers-market-100486 The market for spirometers includes a wide range of products, from basic handheld devices for simple lung function testing to more advanced systems used in clinical settings and hospitals. These devices can be standalone spirometers or integrated into larger diagnostic systems. Factors driving the spirometer market include: 1. Increasing Prevalence of Respiratory Diseases: The rising incidence of respiratory diseases globally, including COPD, asthma, and other conditions, is a major driver for the spirometer market. 2. Aging Population: As the global population continues to age, the demand for respiratory care and diagnostic tools like spirometers is expected to increase. 3. Technological Advancements: Ongoing advancements in technology have led to the development of more accurate and user-friendly spirometry devices, which can further drive market growth. 4. Growing Awareness and Emphasis on Preventive Healthcare: Awareness about the importance of early detection and management of respiratory conditions is leading to increased adoption of spirometry as a diagnostic tool. 5. Regulatory Support: Government regulations and policies mandating the use of spirometry in certain clinical settings can drive market growth. 6. Telemedicine and Remote Monitoring: The COVID-19 pandemic has accelerated the adoption of telemedicine, which may boost the demand for portable and easy-to-use spirometry devices for remote monitoring of respiratory conditions. 7. Increasing Healthcare Expenditure: The overall increase in healthcare spending, especially in emerging markets, can contribute to the growth of the spirometer market. 8. Research and Development: Ongoing research and development in the field of respiratory medicine may lead to the introduction of innovative spirometry technologies.WWW.FORTUNEBUSINESSINSIGHTS.COMSpirometer Market Trends | Key Industry Developments [2030]The global spirometer market size is projected to grow from $613.3 million in 2023 to $891.5 million by 2030, at a CAGR of 5.5% during the forecast period0 Comments 0 Shares 849 Views -
The Cardiac Rhythm Management (CRM) Devices Market refers to the global market for medical devices designed to manage and regulate the electrical activity of the heart. These devices are used to treat various cardiac rhythm disorders, including conditions like arrhythmias, atrial fibrillation, and heart failure.
https://www.fortunebusinessinsights.com/industry-reports/cardiac-rhythm-management-crm-devices-market-100679
The Cardiac Rhythm Management (CRM) Devices Market refers to the global market for medical devices designed to manage and regulate the electrical activity of the heart. These devices are used to treat various cardiac rhythm disorders, including conditions like arrhythmias, atrial fibrillation, and heart failure. https://www.fortunebusinessinsights.com/industry-reports/cardiac-rhythm-management-crm-devices-market-100679WWW.FORTUNEBUSINESSINSIGHTS.COMCardiac Rhythm Management Devices Market Size & Share Report 2030Global Cardiac Rhythm Management Devices Market size stood at USD 13.88 Bn in 2018 and is projected to reach USD 19.93 Bn by 2026, exhibiting a CAGR of 4.4% in the forecast period (2019-2026).0 Comments 0 Shares 805 Views -
The Bone Growth Stimulators Market refers to the industry involved in the production and sale of medical devices or treatments that are designed to enhance the natural healing process of bones. These devices use various technologies, such as electrical stimulation, ultrasound, or other methods, to accelerate and promote bone healing in cases where fractures or other bone injuries have occurred
https://www.fortunebusinessinsights.com/industry-reports/bone-growth-stimulators-market-100161
There are different types of bone growth stimulators:
1. Electrical Bone Growth Stimulators: These devices use low-level electrical currents to stimulate bone healing. They can be worn externally or implanted internally, depending on the specific type.
2. Ultrasound Bone Growth Stimulators: These devices use high-frequency sound waves to stimulate bone healing. They are typically worn externally and are non-invasive.
3. Combined Magnetic Field (CMF) Bone Growth Stimulators: These devices use a combination of static magnetic fields and electrical currents to stimulate bone healing. They are often used for non-union fractures.
The Bone Growth Stimulators Market serves a wide range of patients, including those with delayed or non-union fractures, spinal fusion procedures, and other orthopedic conditions where bone healing is critical.
Factors driving the market may include an aging population, increasing incidents of bone-related disorders, and advancements in medical technology. Additionally, the demand for non-invasive and effective treatment options for bone healing has contributed to the growth of this market.
The Bone Growth Stimulators Market refers to the industry involved in the production and sale of medical devices or treatments that are designed to enhance the natural healing process of bones. These devices use various technologies, such as electrical stimulation, ultrasound, or other methods, to accelerate and promote bone healing in cases where fractures or other bone injuries have occurred https://www.fortunebusinessinsights.com/industry-reports/bone-growth-stimulators-market-100161 There are different types of bone growth stimulators: 1. Electrical Bone Growth Stimulators: These devices use low-level electrical currents to stimulate bone healing. They can be worn externally or implanted internally, depending on the specific type. 2. Ultrasound Bone Growth Stimulators: These devices use high-frequency sound waves to stimulate bone healing. They are typically worn externally and are non-invasive. 3. Combined Magnetic Field (CMF) Bone Growth Stimulators: These devices use a combination of static magnetic fields and electrical currents to stimulate bone healing. They are often used for non-union fractures. The Bone Growth Stimulators Market serves a wide range of patients, including those with delayed or non-union fractures, spinal fusion procedures, and other orthopedic conditions where bone healing is critical. Factors driving the market may include an aging population, increasing incidents of bone-related disorders, and advancements in medical technology. Additionally, the demand for non-invasive and effective treatment options for bone healing has contributed to the growth of this market.0 Comments 0 Shares 877 Views
More Stories